Article

Gastric Cancer Advocate Debbie Zelman Talks About Need for Education and Support

Debbie Zelman is the founder and president of Debbie's Dream Foundation: Curing Stomach Cancer, a nonprofit organization that is dedicated to educating and supporting patients and their families.

Debbie Zelman is the founder and president of Debbie's Dream Foundation: Curing Stomach Cancer, a nonprofit organization that is dedicated to educating and supporting patients and their families.

One goal of the organization is to provide information for patients and their families to better understand the disease.

"Whenever a patient and their family are more educated about a disease, they can more effectively contribute to their care," Zelman says. "We've also found in cancer that the more support a patient has, the better the outcome they have."

Caregivers can bring meals, go to the appointment with them, but also learn and research about the disease and its treatments.

"Whenever anyone is better informed, they can become a better advocate for themselves," she says. "They can say, 'Hey, I heard about this great biomarker that they just now announced at ASCO GI. Can you tell me more about it?'"

Related Videos
Image of woman with blonde hair.
Image of a woman with long red hair.
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Image of a man with short black hair.
Image of a woman with tied back hair, wearing pearl earrings.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Related Content
Image of woman holding picture of intestines.
November 2nd 2024

GERD Might Cause Colonoscopy Avoidance. But Don’t Let It

Kathleen Wiltraut
I initially put off a colonoscopy due to gastroesophageal reflux disease, but after a positive home screening test, I underwent the procedure and was diagnosed with stage 3 rectal cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of woman highlighting pancreas.
November 1st 2024

Early Data Demonstrate Ablation May Alleviate Pain From Pancreatic Cancer

Darlene Dobkowski, MA
In the first 15 patients, radiofrequency ablation was shown to reduce pain scores in most patients with pancreatic cancer.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
image of FDA approval developing story.
Published: October 18th 2024 | Updated: October 18th 2024

FDA Approves Vyloy for HER2-Negative Gastric or GEJ Adenocarcinoma

Alex Biese
The FDA has approved Vyloy for patients with HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma with CLDN18.2-positive tumors.
Image of woman holding image of gallbladder.
October 15th 2024

Avastin Regimen Versus Monitoring May Be Beneficial in Cholangiocarcinoma

Ashley Chan
Patients with gallbladder cancer and cholangiocarcinoma may benefit from receiving Avastin plus Tarceva versus active surveillance.